Heartflow, Inc. Common Stock

NASDAQ:HTFL

Medical - Healthcare Information Services

Healthcare
$45.89 +1.19%

+$0.39 today

Market cap
$4.03B
Beta
1.91
P/E (TTM)
-109.5
EPS (TTM)
-$0.30
52W Low $20.13High $41.22

Volume 1.33M

Average 1.33M

HTFL Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Heartflow, Inc. Common StockNASDAQ: HTFL

Research & Development · Q3 FY2026 · quarter ended Sep 2026

Research & development growth accelerates

Q3 FY2026 research & development of $29.49M rose 70.5% year over year, ahead of the +64.1% change in trailing-twelve-month research & development. Sequentially, it rose 12.3% from the prior quarter.

Context

  • Research & development amounted to 36.9% of revenue in FY2025, up 2.3 pp from a year earlier.
  • Research & development increased in 2 of the last 2 fiscal years.
  • FY2025 was the highest annual figure in the 3 fiscal years shown.

What to watch

Whether quarterly growth of +70.5% holds above the trailing-twelve-month pace of +64.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$29.49M+12.3% QoQ
Last fiscal yearDec 2025
$64.92M+49.2% YoY
LTMSep 2026
$96.03M+64.1% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+70.5%——
1 year+49.2%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
64.92M USD
Year-over-year change
+49.2%
2-year CAGR
+34.6%

Research & Development vs competitors

How HTFL compares with its peers on the latest reported figures

No competitor Research & Development figures are available to compare.

Income Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue87.17M125.81M176.03M
Cost of Revenue29.12M31.36M40.84M
Gross Profit58.05M94.45M135.2M
Gross Margin66.6%75.1%76.8%
Research & Development35.85M43.52M64.92M
Selling, General & Admin95.11M112.15M134.35M
Operating Expenses130.97M155.67M199.26M
Depreciation & Amortization7.59M8.14M8.57M
EBITDA(62.83M)(65.47M)(93.12M)
EBITDA Margin-72.1%-52.0%-52.9%
Operating Income(72.91M)(61.22M)(64.07M)
Operating Margin-83.6%-48.7%-36.4%
Interest Income5.46M4.07M5.54M
Interest Expense24.69M22.77M15.17M
Other Income / Expenses(22.19M)(35.15M)(52.8M)
Income Before Tax(95.11M)(96.37M)(116.87M)
Pre-Tax Margin-109.1%-76.6%-66.4%
Income Tax Expense547K53K(76K)
Net Income(95.66M)(96.43M)(116.79M)
Net Margin-109.7%-76.6%-66.3%
EPS (Basic)(1.94)(1.53)(1.37)
EPS (Diluted)(1.94)(1.53)(1.37)
Weighted Avg Shares63.86M63.06M85.28M
Weighted Avg Shares (Diluted)63.86M63.06M85.28M

Heartflow, Inc. Common Stock

NASDAQ:HTFL

Intrinsic Alpha fair value

Locked

Current Price

$45.89

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.